Medical Xpress on MSN7d
Study identifies 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the diseaseUsing sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...
Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.
Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...
Benzinga on MSN1d
NeuroSense Moves Toward Early Commercialization Of ALS Treatment In Canada, Eyeing $100M+ MarketNeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe ...
The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...
ARLINGTON, Virginia—Ben Baldanza, former president and CEO of U.S. ULCC Spirit Airlines, died Nov. 5 after a long battle with ...
Ben Baldanza, who worked four decades in the US airline industry and helped create the ultra-low-cost model as former chief ...
ATH-1105 – A next-generation, novel, orally administered, small molecule drug candidate in development for the potential treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback